Cholera - The grim reality of under-development

South African Family Practice

Volumn 23, Issue 2, 2001, Pages 4-10

  Durrheim, Dave N ^a   Ogunbanjo, G A ^b   Blumberg, L ^c   Keddy, K H ^c  

^a Mpumalanga Department of Health and Social Services   (South Africa)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cholera; Diagnosis; Multidrug resistance; Rehydration; Vaccination; Vibrio cholerae

Indexed keywords

EID: 0010209326     PISSN: 1726426X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Snow J. On the mode of communication of cholera. The Commonwealth Fund. London: Oxford University Press, 1936.
2. Brody H, Rip MR, Vinten-Johansen P Paneth N, Rachman S. Map-making and myth-making in Broad Street: the London cholera epidemic, 854. Lancet 2000; 356: 64-68.
3. Gangarosa EJ, Mosley WH. Epidemiology and control of cholera. In: Barau D, Burrows W (eds). Cholera. Philadelphia: Saunders, 1974: 381-403.
4. Kustner HGV, du Plessis G. The cholera epidemic in South Africa, 980-1987. Epidemiological features. S Afr Med J 1991; 79: 539-544.
5. Athan E, Donohue S, Durrheim DN. A cholera outbreak and control in a rural region of South Africa. S Afr Med J 1998; 88: 306-1308.
6. SanchezJL, TaylorDN. Cholera, Lancet 1997; 349: 825-1830.
7. Huq A, Colwell RR, Chowdhury MAR, Xu B, Moniruzzaman SM, Islam MS, Yunus M, Albert MJ. Coexistence of Vibrio cholerae O 1 and O 139 Bengal in plankton in Bangladesh. Lancet 1995: 315: 249.
8. Islam MS, Rahim Z, Alam MJ, Begum S, Moniruzzaman SM, et al. Association of Vibrio coerae 01 with the cyanobacterium, Anabaena sp., elucidated by polymerase chain reaction and transmission electron microscopy Trans R Soc Trop Med Hyg 1999; 93: 36-40.
9. Tauxe RV, Mintz MD, Quick RE. Epidemic cholera in the new world: translating field epidemiology into new prevention strategies. Emerg Infect Dis 1995: I: 41-146.
10. Birmingham ME, Lee LA, Ndayimirije N, Nkurikiye S, Hersh BS, Well JG, Deming MS. Epidemic cholera in Burundi: patterns of transmission in the Great RiftValley Lake region. Lancet 1997; 349: 981-985.
11. Rabbani GH. The search for a better or-al rehydration solution for cholera. N EngJ Med 2000: 342: 345-347.
12. Blake PA, Rosenburg ML, Florencia J, Costa JB, Quintino L do P Gangarosa EJ. Cholera in Portugal, 974. II Modes of transmission. Am J Epidemiol 1977; 05: 344-34&.
13. Department of Health. Guidelines for cholera control. Pretoria: Department of Health, 1998.
14. Siddique AK, Salam A, Islam MS, Akram K, Majumdar RN, Zaman K, Fronczak IN, Laston S, Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Gonna, Zaire. Lancet 1995; 359-361.
15. Bartlett AV. Cholera lessons. Lancet 1991; 338: 216.
16. GarnerjS. Guidelines for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 7: 53-80.
17. Keddy KH, Koornhof HJ. Cholera-the new epidemic? S Afr Med J 1998; 88: 313-1314.
18. Scas C, Gotuzzo E. Cholera: overview of epidemiologic, therapeutic, and preventive issues learned from recent epidemics. IntJ Infect Dis 1996; I: 37-46.
19. Burans JP Podgore J, Mansour MM et al. Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistantVibrio cholerae O I. Trans Royal SocTrop Med Hyg 1989: 83: 836-838.
20. Khan WA, Regum M, Salam MA, Bardhan PK, Islam MR, Mahalanabis D. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults. Trans Royal SocTrop Med Hyg 1995; 89: 103-106.
21. KhanWA, Bennish ML, Seas C, Khan EH, Ronan A, et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused byVibrio cholerae O 1 or O 139. Lancet 1996; 348: 296-300.
22. Weber JT Mintz ED, Caniazares R, et al. Epidemic cholera in Ecuador: multidrug resistance and transmission by water and seafood. Epidemiol Infect 1994; 2: 111.
23. World Health Organization. WHO guidance on formulation of national policy on the control of cholera. Geneva: WHO, 1992; WHO/CDD/SER/80. 4.
24. Basu A, Garg P Datta S, Chakraborty S, Bhattacharya T et al. Vibno cholerae O 139 in Calcutta, 1992-1998: incidence, antibiograms and genotypes. Emerg Infect Dis 2000; 6: 139-147.
25. CheastyT Said B, Threlfall Q. V cholerae non-o I: implications for man? Lancet 1999; 354: 89.
26. Durrheim DN, Billinghurst KB, de Bruyn JC, Speare R, Edgington ME. The Outbreak Manual. Durban, Health SystemsTrust, 1998.
27. Gunnlaugsson G, Einarsdottir J, Angulo FJ, Mentambanar SA, Passa ATauxe RV Funerals during the 994 cholera epidemic in Guinea-Bissau, West Africa: the need for disinfection of bodies of persons dying of cholera. Epidemiol Infect 1998; 20: 7-15.
28. Scas C, Gotuzzo E. Cholera: overview of epidemiologic, therapeutic, and preventive issues learned from recent epidemics. Intl Infect Dis 1996; I: 37-46.
29. Steffen R, duPont HL. Travel medicine: what's that? J Travel Med 1994; I:-3.
30. Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV Reported cholera in the United States, 992-1994. A reflection of global changes in cholera epidemiology. JAMA 1996; 276: 307-312.
31. World Health Organization. Cholera: unjustified control measures. Wkly Epidemiol Rec 1994; 45: 337-338.
32. Sanchez JL, Vasquez B. Begue RE, Meza R, Castellares G, et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits, Lancet 1994: 344: 273-1276.
33. Preston NW. Cholera vaccines: lessons from Rwanda and elsewhere, Lancet 1997, 319: 1957.
34. Waldman RJ. Cholera vaccinat'on in refugee settings. JAMA 1998; 279: 552-553.
35. Murray J, McFarland DA, Wladman RJ. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. Bull World Health Organ 1998; 76: 343-352.
36. Ackers M, Quick RE, Drasbek CJ, et al. Are there national risk factors for epidemic cholera? The correlation between socioeconomic and demographic indices and cholera incidence in Latin America. Int J Epidemiol 1998; 27: 330-334.
37. Forrest DM. Control of Imported Communicable Diseases: Preparation and Response. Can J Public Health 1996; 87: 368-372.